Palisade Bio Inc (PALI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2008 | 03-2008 | 12-2007 | 09-2007 | 06-2007 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,232 | -2,275 | -6,174 | -4,169 | -2,748 |
| Depreciation Amortization | 30 | 14 | 32 | 48 | 26 |
| Accounts receivable | N/A | N/A | N/A | N/A | -4 |
| Other Working Capital | -37 | -522 | 566 | 399 | 203 |
| Other Operating Activity | 2,161 | 1,095 | 1,575 | 846 | 479 |
| Operating Cash Flow | $-3,078 | $-1,688 | $-4,001 | $-2,877 | $-2,045 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -61 | -29 | -134 | -101 | -75 |
| Purchase Sale Intangibles | -23 | -3 | -96 | -7 | -5 |
| Other Investing Activity | -23 | -3 | -96 | -7 | -5 |
| Investing Cash Flow | $-84 | $-32 | $-230 | $-108 | $-80 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | -28 | -6 | -4 |
| Common Stock Issued | 2,725 | 2,574 | 9,856 | 6,530 | 6,020 |
| Financing Cash Flow | $2,725 | $2,574 | $9,828 | $6,524 | $6,016 |
| Beginning Cash Position | 7,404 | 7,404 | 1,807 | 1,807 | 1,807 |
| End Cash Position | 6,967 | 8,258 | 7,404 | 5,346 | 5,699 |
| Net Cash Flow | $-437 | $854 | $5,597 | $3,539 | $3,892 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,078 | -1,688 | -4,001 | -2,877 | -2,045 |
| Capital Expenditure | -61 | -29 | -134 | -101 | -75 |
| Free Cash Flow | -3,140 | -1,717 | -4,135 | -2,978 | -2,120 |